Mountainview Energy Ltd has hired Campen Consulting, Inc to conduct a geological study of the acreage, complete with maps, which will enable Management to select locations for the upcoming drilling program to commence during the Second or Third Quarter 2007.
The zones of interest are the Shannon interval, the Second Eagle, Niobrara, Carlisle (Medicine Hat) and the Greenhorn. Other zones of interest are the Muddy and Dakota Sandstone intervals and other potential zones in the Paleozoics.
We are very pleased to work with QMAC ENERGY, INC, as we have had a long-term relationship with the Management of this Company through other ventures. We look forward to developing this Wild Cat play in Southeastern Montana.
MOUNTAINVIEW ENERGY LTD
"Joseph V. Montalban"
Joseph V. Montalban
Chairman of the Board
"Patrick M. Montalban"
Patrick M. Montalban
President & Chief Executive Officer
Recent MSRM News
- Mushrooms Inc. (OTC:MSRM) Launches New Health Supplements, Progresses with German Partnership, and Boosts Engagement Initiatives. • InvestorsHub NewsWire • 03/05/2024 02:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/08/2024 02:55:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 05:18:40 PM
- Mushrooms Inc (OTC:MSRM) Announces Full Patent Filing for Groundbreaking Mycelium Technology Providing Bacterial Detection and Nutrient Delivery. • InvestorsHub NewsWire • 10/18/2023 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/14/2023 02:27:19 PM
- Mushrooms, Inc. (OTC: MSRM) Announces Diverse Business Development Team Assembled to Drive Company Growth. • InvestorsHub NewsWire • 08/23/2023 01:00:00 PM
- Mushrooms, Inc. (OTC: MSRM) is Poised for Textile Innovation and Global Impact as Full Patent Filing for Mycelium Thread Nears Completion. • InvestorsHub NewsWire • 08/08/2023 12:00:00 PM
- Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast. • InvestorsHub NewsWire • 07/19/2023 12:32:27 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM